Predictive value of cell kinetics in endometrial adenocarcinoma

Anticancer Research

Volumn 20, Issue 5 B, 2000, Pages 3569-3574

  Mariani, L ^a   Conti, L ^a   Antenucci, A ^a   Vercillo, M ^a   Atlante, M ^a   Gandolfo, G M ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

DNA ploidy; Endometrial carcinoma; Flow cytometry; Risk factors; S phase fraction; Thymidine labeling index

Indexed keywords

DNA;

ARTICLE; CANCER STAGING; CELL CYCLE S PHASE; CELL KINETICS; DNA CONTENT; ENDOMETRIUM CARCINOMA; FLOW CYTOMETRY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CELL CYCLE; CELL DIVISION; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; S PHASE; THYMIDINE;

EID: 0033636123     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Annual report on the results of treatment in gynecological cancer
2. DNA ploidy, morphometry and nuclear grade as prognostic factors in endometrial carcinoma
3. Aggressive stage I grade I endometrial carcinoma
4. Prognostic significance of ploidy level in human tumors. Carcinoma of the uterus
5. DNA ploidy in endometrial carcinoma: Major obiective prognostic factors
6. DNA content as a prognostic factor in endometrial carcinoma
7. Flow cytometrical DNA and clinical parameters in the prediction of prognosis in stage I-II endometrial carcinoma
8. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer-patients
9. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: Comparison with other clinical-pathological parameters
10. Flow cytometry and interactive immage cytometry in endometrial carcinoma. A comparative study and prognostic study
11. Confirmation of the prognostic value of the ECP-I score (myometrial invasion, DNA ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-up
12. Identification of patients with stage I uterine endometrioid adenocarcinoma at high-risk of recurrence by DNA ploidy, myometrial invasion and vascular invasion
13. Study of cell kinetics in the normal colorectal mucosa of subjects at risk of developing colorectal carcinoma
14. The prognostic significance of DNA measurements in endometrial carcinoma
15. Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinoma
16. Evaluation of DNA ploidy in endometrial cancer
17. Identification of high-risk groups in endometrial carcinoma stage 1-11. A combination of DNA and steroid receptor-measurements identifies early deaths from disease
18. The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma
19. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: A prospective 5-year survival study
20. Flow cytometric studies of ploidy and proliferative indices in the Yorkshire trial of adjuvant progestogen treatment of endometrial cancer
21. Flow-cytometric analysis of nuclear DNA content in endometrial adenocarcinoma
22. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: A prospective 5-year survival study
23. Identification of high risk groups in endometrial carcinoma stage I-II: A combination of DNA and steroid receptor-measurements identifes early deaths from the disease